Skip to main content

Cardiac GRK2 Inhibition via ARKct Augments 2-adrenergic Receptor-dependent Contractility and Survival Post-Myocardial Infarction

Publication ,  Conference
Lvmperopoulos, A; Rengo, G; Gao, E; Bathgate, A; Koch, WJ
Published in: CIRCULATION
2012

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2012

Volume

126

Issue

21

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lvmperopoulos, A., Rengo, G., Gao, E., Bathgate, A., & Koch, W. J. (2012). Cardiac GRK2 Inhibition via ARKct Augments 2-adrenergic Receptor-dependent Contractility and Survival Post-Myocardial Infarction. In CIRCULATION (Vol. 126).
Lvmperopoulos, Anastasios, Giuseppe Rengo, Erhe Gao, Ashley Bathgate, and Walter J. Koch. “Cardiac GRK2 Inhibition via ARKct Augments 2-adrenergic Receptor-dependent Contractility and Survival Post-Myocardial Infarction.” In CIRCULATION, Vol. 126, 2012.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2012

Volume

126

Issue

21

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology